Brief: Oryzon Announces Formal Grant Of Key European Patent For Vafidemstat
Oct 14 (Reuters) - Oryzon Genomics SA ORY.MC :
* FORMAL GRANT OF KEY EUROPEAN PATENT FOR VAFIDEMSTAT
* PATENT TO NOT EXPIRE UNTIL AT LEAST 2038, EXCLUDING ANY
POTENTIAL TERM EXTENSIONS
Source text: https://tinyurl.com/mr2jt33r
Further company coverage: ORY.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28